Emulsion Cross-Linking Technique for Human Fibroblast Encapsulation.

Area of Science:

• Biomaterials Science
• Cell Biology
• Drug Delivery Systems

Background:

• Microencapsulation using biodegradable polymers is a promising technique for drug and cell delivery.
• Current applications include probiotic delivery, highlighting the potential for broader therapeutic uses.
• Encapsulating mammalian cells could revolutionize future disease treatments.

Purpose of the Study:

• To prepare microcapsules of human fibroblast cells (CRL2522) using an emulsion cross-linking technique.
• To optimize microencapsulation parameters for stable particle size, morphology, and cell viability.
• To assess the potential of this method for clinical cell delivery applications.

Main Methods:

• Human fibroblast cells (CRL2522) were encapsulated using an emulsion cross-linking method.
• Tween 80 surfactant was utilized at a 2% concentration during phase inversion to achieve optimal results.
• Particle size, morphology, and cell survival rates were evaluated over a 14-day period.

Main Results:

• The optimal Tween 80 concentration of 2% yielded the most stable microcapsule size and morphology.
• Cell survival rates remained at or above 50% on day 14 post-encapsulation.
• The emulsion cross-linking technique produced smaller, potentially more diverse microcapsules.

Conclusions:

• Emulsion cross-linking is an effective method for microencapsulating human fibroblast cells.
• Optimized conditions using Tween 80 enhance microcapsule stability and cell viability.
• This technology holds significant potential for the clinical development of encapsulated cell delivery systems for disease treatment.